BioIVT Acquires BeCytes Biotechnologies

November 4, 2025

BioIVT has acquired BeCytes Biotechnologies, a Barcelona-based provider of ethically sourced human tissues and primary cell isolation services. The deal expands BioIVT's European footprint and strengthens its capabilities for New Approach Methodologies (NAMs) and ADME research; BeCytes will continue to operate from Barcelona and financial terms were not disclosed.

Buyers
BioIVT
Targets
BeCytes Biotechnologies
Industry
Biotechnology
Location
Catalonia, Spain
Transaction Type
Buyout

Explore More

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.